Drug Patent Seizures Put American Innovation at Risk

A dozen members of Congress called on Health and Human Services Secretary Xavier Becerra to seize the patent for Xtandi, a popular prostate cancer drug earlier this year. They say it costs too much.

 



Comment
Show comments Hide Comments


Related Articles